Policy Analysis: Investment, Life Sciences, Policy
Horizon 2020 Special Coverage
The 2015 Science|Business Annual Summit
The Science|Business Annual Summit brings together leaders from research, industry and policy to debate current and future trends needed to unleash Europe’s technological potential.
Barcelona - 17 November 2015
The future of manufacturing: Industry 4.0
A Science|Business public conference
Brussels - 01 October 2015
The Bioeconomy Challenge: Producing more from less
A Science|Business high-level roundtable
Brussels - 02 July 2015
The new European Commission: Bad news for research and innovation?
Advocates for cross-sectoral R&D support fear a downgrade in the new Commission – but in individual areas such as energy, digital technologies, and pharmaceuticals, a stronger emphasis on growth and investment is good news for many
Published:
Pharma industry agrees collaboration to tackle non-communicable disease

The pharmaceutical sector launched a Framework for Action to tackle non-communicable diseases including cardiovascular disease, cancer, diabetes and chronic respiratory diseases that are posing a threat to public health, and public and private finances worldwide.


Image: Bigstock

The industry’s ten-point framework scopes out specific areas of action including innovation, access and affordability of drugs, prevention and health education. It also underscores the essential role of partnerships and dialogue in implementing the framework.

The framework confirms the industry’s crucial role in continued investment in R&D programmes to develop drugs for the prevention and treatment of non-communicable disease, with over 1,500 products in the pipeline currently. It also commits the industry to target its innovation towards...



Related subjects: Cancer, Diabetes, chronic respiratory disease, non-communicable disease

Advertisement